Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • Trial Manager (1)
  • nct (1)
Country
  • Belgium (2)
  • Czech Republic (2)
  • Finland (2)
  • France (2)
  • Hungary (2)
  • Mexico (2)
  • Netherlands (2)
  • Poland (2)
  • Romania (2)
  • Spain (2)
  • Sweden (2)
  • Australia (1)
  • Colombia (1)
  • Croatia (1)
  • Estonia (1)
  • Germany (1)
  • Italy (1)
  • Korea, Republic of (1)
  • Latvia (1)
  • Lithuania (1)
  • Norway (1)
  • Portugal (1)
  • Russian Federation (1)
  • Slovakia (1)
  • South Africa (1)
  • Switzerland (1)
  • Ukraine (1)
  • United Kingdom (1)
Source
  • nct (2)
Phase
  • complete (2)

Source: nct - Country: Hungary,Finland,Czech Republic,Romania,Netherlands,Mexico
Trial Manager Update Il y a 5 ans

Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause Primary: To assess the efficacy and safety of DVS-233 SR compared with placebo for treatment of vasomotor symptoms (VMS) associated with menopause and to compare the bleeding incidence of DVS-233 SR and tibolone. Secondary: To assess the effects of DVS-233 SR and tibolone on changes from baseline in weight, breast pain, and health outcomes indicators.

  • Country Belgium, Croatia, Czech Republic, Finland, France, Hungary, Mexico, Netherlands, Poland, Romania, South Africa, Spain, Sweden, Ukraine, United Kingdom,
  • organs None
  • Specialty None
Closed trial
More information
nct Update Il y a 5 ans

A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.

  • Country Australia, Belgium, Colombia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Switzerland,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.